2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices
Cardiometabolic Health Congress
JULY 17, 2024
February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.
59 
Let's personalize your content